CME vs V
Based on Invest's signal, VISA Inc. (V) currently has the stronger Buy/Hold/Sell rating of the two — a hold versus hold for CME.
| Metric | CME | V |
|---|---|---|
| Price | $255.31 | $355.74 |
| Day change | +0.4% | +1.2% |
| Market cap | $92.2B | $676.5B |
| P/E ratio | 21.7 | — |
| 1-year return | -7.7% | +0.1% |
| Invest signal | Hold | Hold |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying CME and V at live prices.
CME vs V: FAQ
Is CME or V the better stock to buy?
Based on Invest's signal, VISA Inc. (V) currently has the stronger Buy/Hold/Sell rating of the two — a hold versus hold for CME. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, CME or V?
VISA Inc. is the larger company by market capitalisation ($676.5B vs $92.2B).
Can I practice trading CME and V for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both CME and V at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.
